News

Venaxis Reports Option Inducement Grants for New Employees Under NASDAQ Listing Rule 5635(c)(4)

Venaxis®, Inc., announced that on September 21, 2016, the Company approved the grant of stock options to six new employees, hired in connection with the Company’s acquisition of BiOptix Diagnostics, Inc., to purchase an aggregate of 95,000 shares of common stock.  Read more…


Venaxis Issues Shareholder Update

Venaxis®, Inc. announced today that following its acquisition of BiOptix Diagnostics, Inc., (“BiOptix”) that was announced on September 13, 2016, Venaxis has issued the following letter to its shareholders.  Read more…


Venaxis Announces Acquisition of BiOptix

Venaxis® announced today that it has acquired BiOptix Diagnostics, Inc., (“BiOptix”) a Boulder, CO-based privately-held company. Venaxis will host an investor conference call to discuss the transaction on Wednesday, September 14, 2016, at 8:45 a.m. ET.  Read more…